La Merie

La Merie Daily

La Merie Daily is a FREE Newsletter which can be signed up at PipelineReview.com. The Newsletter brings by e-mail daily updates about biopharmaceutical R&D and related business with a brief summary and the corresponding hyperlink leading to the original press releases posted on PipelineReview.com.
Subscribe to La Merie Daily

[ top of the page ]

R&D Pipeline News

R&D Pipeline News is a weekly tool for biopharmaceutical R&D analysis in two editions and is available by annual subscription. R&D Pipeline News Technology or Therapeutic Area Edition keeps up-to-date with the latest R&D projects of the biopharmaceutical industry, with all the relevant treatment modalities and with competitive information about ongoing R&D projects for a given Target, Technology or Company. The R&D information is presented in an easy- and rapid-to-screen tabular format and grouped either in Therapeutic Areas or Product Categories. News are listed in groups according to the product category, e.g. antibodies or vaccines etc. or in Therapeutic Areas, e.g. oncology or cardiovascular. The product is delivered every week as a PDF directly to the desktop via e-mail.
Get a 3-weeks FREE TRIAL of R&D Pipeline News

[ top of the page ]

Competitor Analysis

The Competitor Analysis Series delivers NO-FRILLS , but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices . The information is provided in a tabular format and fully referenced. Competitor analysis reports can be purchased as a la carte or obtained by subscribing to R&D Pipeline News . R&D Pipeline News is published weekly 50-times a year and each issue contains competitor evaluations. Individual products from the Competitor Analysis Series and R&D Pipeline News are independently elaborated by analysts of La Merie Business Intelligence and distributed by PipelineReview.com.
Have a look at Competitor Analysis

[ top of the page ]

Reports

Full reports from publishers such as Datamonitor, Business Insight or La Merie provide in depth analysis of and insight into biopharmaceutical R&D, technologies, markets and business trends. The reports can be obtained in La Merie’s Online Store PipelineReview.com. The purchase process includes secure online payment with credit card and download of the pdf product at the end of the purchase process or delivery via e-mail within 24 hrs. Products and subscriptions can also be ordered via e-mail, fax or phone and payment is feasible by bank transfer or check.
See examples of Reports

[ top of the page ]

Biotech Features

Biotech Features are published by La Merie in La Merie Daily and in PipelineReview.com and provide free information. Recently published issues were on subjects such as Diabetes, Biogenerics and Cholesterol Management.
Read past Biotech Features

[ top of the page ]

FREE Downloads

La Merie serves the biopharmaceutical community with FREE downloads providing business insight into markets and the biopharmaceutical business. Recent downloads are TOP 20 Biologics and Blockbuster Drugs 2006. TOP 20 Biologics provides a compilation of the 2006 sales of recombinant biologic products including antibodies, proteins and peptides. The report provides an overview of the 20 best selling biologics (TOP 20 Biologics) and 2006 sales for each class of biologics as well as for some selected biologics. Blockbuster Drugs 2006 contains a compilation of the 114 blockbuster drugs with 2006 sales of more than US$ 1 bln each. The report provides an overview of the TOP 10 companies with the highest sales produced by their blockbuster drug portfolio, the TOP 10 best selling blockbuster drugs in 2006, the TOP 10 Blockbuster Drug Classes with the corresponding sales in 2006 and compiles all 114 individual blockbuster drugs of 2006 by company.
Download our FREE Reports

[ top of the page ]